Disclosures
Johnson & Johnson, and Boston Scientific Corp
BLOOD, HEART, LUNG
Dr Zeitler reports research support from Biosense Webster and Sanofi; research grant from Boston Scientific; consulting for Biosense Webster, Boston Scientific, and Medtronic; travel support from Medtronic. Dr Russo reports research trials funding to the hospital (Boston Scientific, BMS‐Pfizer, Medilynx, Medtronic); consulting (Abbott, Atricure, Biosense Webster, Boston Scientific, Medtronic, PaceMate); honoraria/speaking (Biotronik, BMS/Pfizer, Medtronic, Sanofi). Dr Poole reports research grants paid directly to the University of Washington from Biotonik, Kestra Medical, and AtriCure. Dr Al‐Khalidi reports grants from the National Institutes of Health/National Heart, Lung, and Blood Institute and Mayo Clinic during the conduct of the study. Dr Lee reports grants from the National Institutes of Health/National Heart, Lung, and Blood Institute and Mayo Clinic; data and safety monitoring board service on studies funded by Astra‐Zeneca, Medtronic, Merck, Amgen, and the Cardiovascular Research Foundation during the conduct of the study. Dr Bahnson reports grants from the National Institutes of Health/National Heart, Lung, and Blood Institute and Mayo Clinic during the conduct of the study; grants from St. Jude Medica, Abbott Medical, Biosense Webster, Johnson & Johnson, and Boston Scientific Corp; consulting from Cardiofocus outside of the submitted work. Dr Packer in the past 12 months has provided consulting services for Abbott, AtriFix, Biosense Webster, Cardio Syntax, EBAmed, Johnson & Johnson, MediaSphere Medical, MedLumics, Medtronic, NeuCures, St. Jude Medical, Siemens, Spectrum Dynamics, Centrix, Thermedical, and Xenter. Dr Packer received no personal compensation for these consulting activities, unless noted. Dr Packer receives research funding from Abbott, Biosense Webster, Boston Scientific/EPT, CardioInsight, EBAmed, Medtronic, NeuCures, Siemens, St. Jude Medical, Thermedical, National Institutes of Health, Robertson Foundation, Vital Project Funds, Xenter, Mr and Mrs J. Michael Cook/Fund. The Mayo Clinic and Dr Packer have a financial interest in Analyze‐AVW technology that may have been used to analyze some of the heart images in this research. In accordance with the Bayh‐Dole Act, this technology has been licensed to commercial entities, and both Mayo Clinic and Dr Packer have received royalties >$10 000, the federal threshold for significant financial interest. In addition, Mayo Clinic holds an equity position in the company to which the AVW technology has been licensed. Dr Packer and Mayo Clinic jointly have equity in a privately held company, EBAmed; and received royalties from John Wiley & Sons, Oxford, and St. Jude Medical. Dr Packer has a licensing agreement with the American Heart Association for the MAFSI survey and has contractual rights to receive future royalties under this license. Dr Mark reports grants from the National Institutes of Health/National Heart, Lung, and Blood Institute and Mayo Clinic during the conduct of the study; grants from Merck and HeartFlow; and personal fees from Novartis outside the submitted work. The remaining authors have no disclosures to report.